News

Emergency Use Authorization

Reuters | Equities.com |

U.S. health regulators have approved Roche's arthritis drug Actemra for emergency use to treat hospitalized COVID-19 patients, giving an extra boost to a medicine that was already allowed to be administered on compassionate grounds.

The U.S. Food and Drug Administration (FDA) said on Thursday it had issued an emergency use authorization (EUA) for Actemra to treat adults and pediatric patients hospitalized with COVID-19.


Kimberly Redmond | Equities.com |

The US Food and Drug Administration (FDA) issued emergency use authorizations for three COVID-19 screening tests.

Two of these authorizations — granted to Quidel Corp (Nasdaq: QDEL) and Abbott Laboratories (NYSE: ABT) — cover over-the-counter versions of a screening test, while a third — granted to Becton, Dickinson and Co (NYSE: BDX) — covers a prescription test.